April 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

TOPICAL ANTIFUNGALS NAFTIN CREAM (G) NAFTIFINE HCL 2% New Strength ANTI-NEOPLASTIC-MTOR KINASE INHIBITORS AFINITOR TABLET EVEROLIMUS 7.5 MG New Strength IMMUNOMODULATORS ZYCLARA CRM MD PMP IMIQUIMOD 3.75% New Dosage Form MIOTICS/ OTHER INTRAOC. PRESSURE REDUCERS ZIOPTAN OPHTH DROPERETTE TAFLUPROST/ PF 0.0015% New Entity TOPICAL ANTI-NEOPLASTIC & PRE-MALIGNANT LESION AGNTS TOPICAL ANTI-NEOPLASTIC & PRE-MALIGNANT LESION AGNTS PICATO GEL (EA) INGENOL MEBUTATE 0.015% New Entity PICATO GEL (EA) INGENOL MEBUTATE 0.05% New Entity CEPHALOSPORINS – 1 ST GENERATION CEFAZOLIN IV PIGGYBACK CEFAZOLIN SODIUM/ DEXTROS, ISO 2 G/ 50 ML New Strength ANTIVIRALS, HIV-SPECIFIC, FUSION INHIBITORS FUZEON SUB-Q VIAL ENFUVIRTIDE 90MG New Dosage Form GENERAL ANESTHETICS, INJECTABLE MIDAZOLAM HCL DISP SYRIN MIDAZOLAM HCL 40 MG/ 8 ML New Strength GENERAL ANESTHETICS, INJECTABLE MIDAZOLAM HCL DISP SYRIN MIDAZOLAM HCL 125 MG/ 25 ML New Strength SKIN TISSUE REPLACEMENT GRAFIX PRIME TOPICAL SHEET HUMAN REGENER- ATIVE TISSUE MTRX 2 CM X 2 CM New Entity SKIN TISSUE REPLACEMENT GRAFIX PRIME TOPICAL SHEET HUMAN REGENER- ATIVE TISSUE MTRX 5 CM X 5 CM New Entity SKIN TISSUE REPLACEMENT GRAFIX PRIME TOPICAL SHEET HUMAN REGENER- ATIVE TISSUE MTRX 7.5 CM X 15 CM New Entity MIOTICS/ OTHER INTRAOC. PRESSURE REDUCERS COSOPT PF OPHTHALM DROPERETTE DORZOLAMIDE/ TIMOLOL/ PF 2% - 0.5% New Formulation ANTI-ARRHYTHMICS LIDOCAINE HCL DISP SYRIN LIDOCAINE HCL/ PF 30MG/ 3 ML New Strength GENERAL ANESTHETICS, INJECTABLE KETAMINE HCL DISP SYRIN KETAMINE HCL 100 MG/ ML New Route and Dosage Form 4
GENERAL ANESTHETICS, INJECTABLE MIDAZOLAM HCL – 0.9% NACL DISP SYRIN MIDAZOLAM HCL IN 0.9% NACL/ PF 0.5 MG/ ML New Strength ANTI-ANXIETY DRUGS DIAZEPAM SOLUTION DIAZEPAM 5 MG/ CUP New Strength and Dosage Form ANALGESICS, NARCOTICS MORPHINE SULFATE- 0.9% NACL IV VIAL MORPHINE SULFATE IN 0.9% NACL 1 MG/ ML (1) New Dosage Form ANALGESICS, NARCOTICS FENTANYL CITRATE- 0.9% NACL DISP SYRIN FENTANYL CITRATE – 0.9% NACL/ PF 10 MCG/ ML New Dosage Form ANALGESICS, NARCOTICS TRAMADOL HCL CPMP 25-75 TRAMADOL HCL 150 MG New Strength LOCAL ANESTHETICS ROPI-VACAINE HCL- 0.9% NACL DISP SYRIN ROPIVACAINE HCL IN 0.9% NACL/PF 40MG/ 20ML New Strength ANALGESICS, NARCOTICS SUBSYS SUBLINGUAL SPRAY FENTANYL 100 MCG New Dosage ANALGESICS, NARCOTICS SUBSYS SUBLINGUAL SPRAY FENTANYL 400 MCG New Dosage ANALGESICS, NARCOTICS SUBSYS SUBLINGUAL SPRAY FENTANYL 200 MCG New Dosage ANALGESICS, NARCOTICS SUBSYS SUBLINGUAL SPRAY FENTANYL 600 MCG New Dosage ANALGESICS, NARCOTICS SUBSYS SUBLINGUAL SPRAY FENTANYL 800 MCG New Dosage ANALGESICS, NARCOTICS SUBSYS SUBLINGUAL SPRAY FENTANYL 1200 MCG New Dosage ANALGESICS, NARCOTICS SUBSYS SUBLINGUAL SPRAY FENTANYL 1600 MCG New Dosage SYMPATHOMIMETIC AGENTS PHENYLEPHRINE HCL- D5W IV PLAST. BAG PHENYLEPHRINE HCL/ D5W/ PF 50 MG/ 250ML New Strength ANTI-HISTAMINES – 1 ST GENERATION DIPHENHYDRAMINE – NS IV PIGGYBACK DIPHENHYDRAMINE IN 0.9% NACL 25 MG/ 50ML New Dosage Form and Route ANTI-HISTAMINES – 1 ST GENERATION DIPHENHYDRAMINE – NS IV PIGGYBACK DIPHENHYDRAMINE IN 0.9% NACL 50 MG/ 50ML New Dosage Form and Route 5
Page 1 and 2: April 2012 Drug Information Update
Page 3: First-Time Generics GENERIC DRUG NA
Page 7 and 8: Gruenhaupt, Mark R.Ph. Argus Health
Page 9 and 10: Statin Drugs - Drug Safety Communic
Page 11 and 12: Vytorin (ezetimibe/simvastatin) Tab
Page 13 and 14: low blood sugar (hypoglycemia) in p
Page 15 and 16: Some women with depression who beco
Page 17 and 18: Survival increased for all groups o
Page 19 and 20: finding that it also may reduce the
Page 21 and 22: Syringes (2 mL size), Rx only. NDC
Page 23 and 24: Patheon Pharmaceuticals Inc., Cinci
Page 25 and 26: 50-ct. bottles (NDC 0067-6238-50);
Page 27 and 28: PRODUCT (Class II) 1) Ventolin HFA
Page 29 and 30: Lot #: 0693, Exp: 10/2012 RECALLING
Page 31 and 32: 24 (Display case UPC# 3030045074923
Page 33 and 34: CODE Lot # 139961 RECALLING FIRM/MA
Page 35 and 36: Reason for the Shortage • Teva co
Page 37 and 38: Reason for the Shortage • Ben Ven
Page 39 and 40: Products Affected - Description Gan
Page 41 and 42: 37.5 mg/25 mg, 1000 count (NDC 0078
Page 43 and 44: Acyclovir tablets, Major 400 tablet
Page 45 and 46: 500 mg, 100 count (NDC 63304-0726-0
Page 47 and 48: 750 mg tablets, 100 count (NDC 1013
Page 49 and 50: • Bedford Laboratories has multip
Page 51 and 52: Daunorubicin Hydrochloride Injectio
Page 53 and 54: Ciprofloxacin Immediate-Release Tab
Page 55 and 56:
• APP had tobramycin 40 mg/mL pre
Page 57 and 58:
• Ben Venue voluntarily suspended
Page 59 and 60:
50 mg/mL, 10 mL vial, package of 10
Page 61 and 62:
2 mL vial, preservative-free (NDC 6
Page 63 and 64:
5 mg single dose vial, package of 1
Page 65 and 66:
20 mL glass ampule, sterile pack (N
Page 67 and 68:
2 mL iSecure syringe (NDC 00406-112
Page 69 and 70:
Lidocaine 0.5% Xylocaine 0.5% injec
Page 71 and 72:
• Teva discontinued all ciproflox
Page 73 and 74:
Nicardipine hydrochloride injection
Page 75 and 76:
Article link: http://www.ashp.org/D
Page 77 and 78:
• Apotex had metformin products u
Page 79:
• Covis purchased all rights to F
show all

April 2012 Drug Information Update - Pharmacy Benefits ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?